Chairman of Scopus Biopharma Inc. (NASDAQ:SCPS), Lamstein Joshua R, buys 500 shares worth $5,465

According to Scopus Biopharma Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 19 10:12 AM, company Chairman, Lamstein Joshua R disclosed buying 500 shares at a cost of $10.93. At the time of this transaction (Feb 19), this trade was worth $5,465 in total. As of Feb 19, Lamstein Joshua R now owns 116,697 shares in total worth about $1,276,665.18.

For the last few recent trades made by Scopus Biopharma Inc. (NASDAQ:SCPS) Chairman, Lamstein Joshua R, we have the following information:

    Posted by on Friday February 19 2021, 10:20 AM EST. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0

    Comments are closed

    Featured Press Releases

    Log in